Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 0 | 0 | 930 | 0 | 0 |
| Cost of Goods | N/A | N/A | 380 | 0 | 0 |
| Gross Profit | N/A | N/A | 550 | 0 | 0 |
| Operating Expenses | 2,022 | 352 | 4,080 | 1,220 | 1,280 |
| Operating Income | -2,022 | -352 | -3,150 | -1,220 | -1,280 |
| Interest Expense | 107 | 6 | 0 | 0 | 0 |
| Other Income | 10 | -780 | 1,410 | 20 | 30 |
| Pre-tax Income | -2,119 | -1,138 | -1,740 | -1,200 | -1,250 |
| Net Income Continuous | -2,119 | -1,138 | -1,390 | -1,207 | -1,257 |
| Net Income Discontinuous | -746 | -2,575 | 0 | 0 | 0 |
| Minority Interests | -338 | -1,237 | N/A | N/A | N/A |
| Net Income | $-2,527 | $-2,476 | $-1,740 | $-1,200 | $-1,250 |
| EPS Basic Total Ops | -0.22 | -1.10 | -0.60 | -0.50 | -0.50 |
| EPS Basic Continuous Ops | -0.18 | -0.51 | -0.60 | -0.60 | -0.55 |
| EPS Basic Discontinuous Ops | -0.06 | -1.15 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.22 | -1.10 | -0.60 | -0.50 | -0.50 |
| EPS Diluted Continuous Ops | -0.18 | -0.51 | -0.60 | -0.60 | -0.55 |
| EPS Diluted Discontinuous Ops | -0.06 | -1.15 | N/A | N/A | N/A |
| EBITDA(a) | $-1,969 | $1,690 | $-3,150 | $-1,130 | $-1,240 |